US trade deficit hits record high as businesses and consumers rush to import goods before tariffs take effect.
Vertex Pharmaceuticals reports mixed Q1 2025 results, with revenue rising but missing expectations, and faces intellectual property issues in Russia, but raises 2025 guidance and sees strong uptake for its new pain drug.
Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.
US trade deficit hits record high as businesses and consumers rush to import goods before tariffs take effect.
Vertex Pharmaceuticals reports mixed Q1 2025 results, with revenue rising but missing expectations, and faces intellectual property issues in Russia, but raises 2025 guidance and sees strong uptake for its new pain drug.
Trump DOJ moves to dismiss lawsuit challenging FDA's approval of abortion pill mifepristone, citing procedural issues rather than merits of the drug's approval.